Vanguard Group Inc Qualigen Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.46 - $0.93 $65,642 - $132,711
-142,700 Reduced 12.21%
1,026,272 $584,000
Q4 2021

Feb 14, 2022
SELL
$0.94 - $2.56 $6,555 - $17,853
-6,974 Reduced 0.59%
1,168,972 $1.25 Million
Q3 2021

Nov 12, 2021
BUY
$1.18 - $2.06 $179,401 - $313,192
152,035 Added 14.85%
1,175,946 $1.53 Million
Q2 2021

Aug 13, 2021
BUY
$1.53 - $2.75 $1.57 Million - $2.82 Million
1,023,911 New
1,023,911 $2.04 Million

About Qualigen Therapeutics, Inc.

QLGN Quotes by TradingView
  • Ticker QLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,795,500
  • Market Cap $157M
  • Description
  • Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate ...
More about QLGN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email